Subscribe To
Syfovre® (pegcetacoplan injection) continued to demonstrate increasing treatment effects over 3 years in patients with geographic atrophy (ga)
SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE extension study Well-demonstrated...
November 4, 2023, 5:37 pm
Camping world holdings: we are not buyers after the earnings results
Camping World Holdings' stock has performed poorly this year, losing 12% of its market cap. Q3 revenue declined by 6.8% year-over-year, indicating sof...
November 4, 2023, 5:30 am
Vig: a bet on the u.s. economy
Vanguard Dividend Appreciation ETF is a good option for new investors or those seeking safety and stabi...
November 4, 2023, 2:58 am
Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting
– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potential...
November 3, 2023, 8:05 pm
Prime medicine reports third quarter 2023 financial results and provides business updates
— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...
November 3, 2023, 8:01 pm
Kineta reports third quarter 2023 financial results and provides corporate update
Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial...
November 3, 2023, 8:01 pm
Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld
Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of bela...
November 3, 2023, 12:00 pm
Annaly capital management: this 16.6% yielding trust is a bargain (upgrade)
Stock price weakness in Annaly Capital Management presents an attractive entry point into the largest mortgage real estate investment trust. Despite w...
November 3, 2023, 11:39 am
Telus 3q profit plunges as customer gains drive revenue higher
TELUS Corporation (TSX:T) said its profit shrank by 75% in the third quarter due to restructuring charges and higher depreciation, amortization and f...
November 3, 2023, 9:39 am
Musk predicts end to work as ai summit wraps up
Elon Musk ended the UK's first AI safety with another slew of warnings warning, this time over the futu...
November 3, 2023, 4:48 am
'helpful' ai could carry out illegal insider trades and cover its tracks, research finds
Artificial intelligence (AI) systems might have the potential to engage in unauthorized financial transactions and subsequently deny such actions, acc...
November 3, 2023, 4:08 am
Live: friday cheer beckons for indian equities; tata motors q2 impresses| titan, zomato q2 today
A collection of the most-viewed Moneycontrol videos. ‘Prepare for the worst’: Elon Musk warns of potential AI risks at UK ‘AI ...
November 3, 2023, 3:29 am
Alaska airlines sued over attempt by off-duty pilot to shut down engines
Three passengers who were aboard an Alaska Airlines jet when an off-duty pilot riding in the cockpit "jump seat" allegedly tried to disable the plane'...
November 3, 2023, 1:10 am
Automotive abs and esc market to be worth us$ 4,069.95 million at a cagr of 11.2% by the year 2033 | future market insights, inc.
Strict safety regulations in the United States have spurred the widespread adoption of Anti-Lock Brakin...
November 3, 2023, 12:30 am
Hsbc sees a 'few hundred' potential use cases for generative ai: hk ceo
HSBC's Hong Kong CEO Luanne Lim says the bank is embracing artificial intelligence, but wants to make sure the balance between security and investor <...
November 2, 2023, 10:41 pm
Alexandria real estate: a fast-growing and fairly valued reit
Alexandria Real Estate Equities specializes in developing Class A/A+ properties for the life science, agtech, and advanced technology industries. Desp...
November 2, 2023, 8:15 pm
Top 3 penny stocks ready to take off in q4 2023
After a sharp sell-off since mid-summer, many investors are looking for the safety of quality, blue-chi...
November 2, 2023, 6:00 pm
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in patients with hematologic malignancies; up...
November 2, 2023, 1:17 pm
Reckitt and diageo favoured by jp morgan as investors seek 'safety' in consumer staples
Investors are turning defensive in the consumer stocks sector, according to JP Morgan with evidence from the latest quarterly earnings season suggesti...
November 2, 2023, 11:02 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 po...
November 2, 2023, 9:10 am